Health News Releases

  • Today April 23
June 30, 2021 11:30
Ferring Presents New Data at ESHRE 2021 Supporting the Use of Rekovelle® (follitropin delta) for Individualized Fertility Treatment
New data, presented today at the 37th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), show a comparable ongoing pregnancy rate of 31.3% with the individualised dos
June 29, 2021 11:20
Covetrus Introduces New Roles and Leadership Within Its North America & Global Businesses
Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced the appointments of Bekki Kidd and András Bolcskei to the roles of head of North America Operations & Glob
June 29, 2021 10:15
Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, and Galderma, the world’s largest independent dermatology company, today announced they have signed two exclusive 5-yea
June 28, 2021 17:25
Empagliflozin reduced the risk of cardiovascular events and hospitalization for heart failure compared to DPP-4 inhibitors in people with type 2 diabetes
The first data from Europe, Israel and East Asia in the EMPRISE real-world evidence study have been presented, revealing a risk reduction in cardiovascular outcomes associated with empagliflozin compa
June 28, 2021 16:30
Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute
Waters Corporation (NYSE:WAT) today announced an expansion of its joint work with the Bioprocessing Technology Institute (BTI), a research institute of Singapore's Agency for Science, Technology and R
Fresenius Medical Care's Korea Training Center
June 28, 2021 11:55
Fresenius Medical Care Supports Education for Healthcare Professionals in Korea With the Opening of Its First Training Center
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, recently announced the grand opening of its first training center in Korea, to offer
June 28, 2021 11:40
Cambridge University Spin-out Lucida Medical Joins GE Healthcare Edison™ Accelerator Programme
Cambridge start-up Lucida Medical has today announced that it has joined the Edison Accelerator, a programme designed by GE Healthcare in partnership with innovation organisation Wayra UK, to support
June 25, 2021 15:40
Invivoscribe Launches Grant Program to Support Novel Applications for Sequence-Based Analyses of the Immune System
Invivoscribe, a global leader in precision diagnostics, has announced the launch of an Immune Biomarker Discovery grant program, focused on supporting development, validation and deployment of novel a
June 25, 2021 13:40
Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma
Regulatory News: Abbas Hussain (56, British citizen) has a successful and international career of more than 30 years as an executive in the healthcare sector. From 2008 to 2017, Abbas Hussain held
June 25, 2021 11:10
Vifor Pharma to revise DIAMOND study, readout expected in H2 2021
Regulatory News: Vifor Pharma Group today announced that the phase-IIIb DIAMOND study has been amended with new and clinically relevant endpoints, including a new primary endpoint of efficacy in po
June 24, 2021 16:10
Sherlock Biosciences’ 221b Foundation Enables Global Access to COVID-19 Diagnostics with Up To 10 Million Tests Per Month
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that its partn
June 24, 2021 10:30
Oral-B Encourages Consumers to Brush up on Their Oral Care Regimen and Recognise Its Importance to Overall Body Health
Oral-B has teamed up with Scientific American and its Custom Media Division (SACM) to explore the latest research connecting oral health and overall health; as many are unaware of the impact chronic p
June 23, 2021 11:45
LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates
Iksuda Therapeutics, the developer of a new generation of antibody drug conjugates (ADCs) with raised therapeutic index, today announced that it has expanded its research collaboration and License Agr
Sky Labs CART-I, the world’s first AI-based ring-type heart monitoring platform
June 23, 2021 10:14
Sky Labs Finalizes Series B Round Successfully Planning to Take Over Global Markets
Attracting USD 20 million investment, Sky Labs (CEO: Jack Lee), a global health care start-up, finalized Series B Round successfully. The accumulated amount of investment Sky Labs has attracted is USD
June 22, 2021 11:45
Jardiance® (empagliflozin) approved in Europe for the treatment of heart failure with reduced ejection fraction
The European Commission has granted marketing authorization for Jardiance® (empagliflozin) as a treatment for adults with symptomatic chronic heart failure with reduced ejection fraction (systolic hea
June 18, 2021 14:00
Pattern Computer Develops Accurate 15-Second COVID-19 Test
Pattern Computer,® Inc. (PCI) has developed a novel test for near real-time (15 sec) diagnosis of SARS-CoV-2 infections. In contrast with widely used antibody and PCR tests, which take at least 15 min
June 17, 2021 16:50
Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings
Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe
June 17, 2021 14:45
Organon Completes Acquisition of Alydia Health - A Medical Device Company Focused on Postpartum Hemorrhage
Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal m
June 16, 2021 13:40
Diabetes Center Berne Launches Its First Open Innovation Challenge and Supports the Most Promising Ideas Submitted With Coaching, Expertise and a Total of 200,000 USD in Funding
In the last few years, diabetes technology has made enormous progress in improving the lives of people living with diabetes. However, there is still a great unmet need for innovative technology soluti
June 15, 2021 14:40
Humanigen Initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA)
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’, today announced it has ini
June 15, 2021 10:40
New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung Ventilation
Masimo (NASDAQ: MASI) announced today the findings of a study published in the Turkish Journal of Medical Sciences in which Dr. Ayten Saracoglu and colleagues at the Marmara University Pendik Training
June 11, 2021 09:41
Gummy Vitamin Sales Rising in Asia as Focus on Preventing Micro-nutrient Deficiency Increases: Study
The gummy vitamin market in East Asia is anticipated to witness high demand across China and South Korea, opines award winning market research firm Fact.MR in a market study. Rising prevalence of chro
June 10, 2021 17:05
Safeguard DNA Diagnostics Launches Rhinostics Dry Collection Swabs for COVID Testing as Primary Collection Devices for Its Laboratories in the Philippines
Safeguard DNA Diagnostics Inc, SDDI, one of the largest chains of infectious disease laboratories in the Philippines, has introduced COVID sample collection using the Rhinosticsᵗᵐ dry nasal and nasoph
June 09, 2021 17:30
Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China
Today Invivoscribe, a global leader in precision diagnostics, announced the launch of a new 12-color multiparametric flow cytometry service in Shanghai, China, the newest reference laboratory in their
June 09, 2021 14:40
ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)
ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine today announced that the first patient has been enrolled in a clinical trial evaluating Nantheia™ A1002N5S
25 per page50 per page75 per page100 per page